Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 3931 AL 3945

Combination Supplement Therapy: A New Frontier in Treatment of Neurodegenerative Diseases

Shtilbans A.

J Nutr. 2025 Jul 15:S0022-3166(25)00427-4. doi: 10.1016/j.tjnut.2025.07.004. Online ahead of print.

Insights into the toxic effects of micro-nano-plastics on the human brain and their relationship with the onset of neurological diseases: A narrative review

Balistreri CR, Magro D, Jadavji NM.

Ageing Res Rev. 2025 Sep;111:102836. doi: 10.1016/j.arr.2025.102836. Epub 2025 Jul 15.

The costs and benefits of deep brain stimulation in Parkinson's disease: a review and social network analysis

Zúñiga-Ramírez C, Farías-Moreno KC, Moreno G, Gómez-Figueroa E, Caicedo-Ortíz HE, Carrillo-Ruíz JD.

Arq Neuropsiquiatr. 2025 Jul;83(7):1-11. doi: 10.1055/s-0045-1809996. Epub 2025 Jul 17.

High-intensity focused ultrasound (HIFU) versus deep brain stimulation (DBS) for refractory tremor: team HIFU

Massruhá KS, Cardoso EF.

Arq Neuropsiquiatr. 2025 Jul;83(7):1-4. doi: 10.1055/s-0045-1809660. Epub 2025 Jul 17.

How Common Is Pain in Neurologic Disorders and Why Should Neurologists Care?

Singla P, Argoff CE.

Neurol Clin. 2025 Aug;43(3):457-465. doi: 10.1016/j.ncl.2025.04.001. Epub 2025 Jun 11.

Efficacy and safety of fecal microbiota transplantation in the management of parkinson's disease: a systematic review

Nabil Y, Helal MM, Qutob IA, Dawoud AIA, Allam S, Haddad R, Manasrah GM, AlEdani EM, Sleibi W, Faris A, Hassan AK, Nandwana V.

BMC Neurol. 2025 Jul 17;25(1):291. doi: 10.1186/s12883-025-04105-8.

Efficacy of repetitive transcranial magnetic stimulation in cognitive impairment of neurodegenerative diseases: a systematic review and meta-analysis

Zhang Y, Xu K, Wang Y, Shen Y, Liu Z, Zhang C, Zhou Y, Lv P, Bai Y, Wang S.

BMC Neurol. 2025 Jul 17;25(1):295. doi: 10.1186/s12883-025-04292-4.

Exosomes and Their miRNA as a Potential Biomarker in the Diagnosis of Parkinson's Disease

Vijayakumar S, Yesudhason BV, Anandharaj JL, Kalaivanan L, Selvan Christyraj JRS.

ACS Chem Neurosci. 2025 Aug 6;16(15):2756-2766. doi: 10.1021/acschemneuro.5c00313. Epub 2025 Jul 17.

Towards Adaptive Deep Brain Stimulation for Non-Motor Symptoms in Parkinson's Disease?

Swinnen BEKS, Hoy CW, Little SJ.

Mov Disord. 2025 Sep;40(9):1759-1777. doi: 10.1002/mds.30212. Epub 2025 Jul 18.

Subacute Painful Axonal Polyneuropathy Associated with Foslevodopa/Foscarbidopa Subcutaneous Infusion in Advanced Parkinson's Disease

Valli A, Scheperjans F.

Mov Disord. 2025 Nov;40(11):2538-2539. doi: 10.1002/mds.30297. Epub 2025 Jul 18.

The Benefit of Exclusive Nocturnal Levodopa-Carbidopa Intestinal Infusion for Severe Refractory Sleep Behavior Disorder in Parkinson's Disease

Rivera-Sánchez M, Sánchez-Rodríguez A, Manrique L, Sierra M, González-Aramburu I, Sánchez-Peláez MV, Martínez M, López-Delgado A, Infante J.

Mov Disord Clin Pract. 2025 Dec;12(12):2379-2381. doi: 10.1002/mdc3.70237. Epub 2025 Jul 18.

Summary of the best evidence for non-pharmaceutical interventions for mild cognitive impairment in Parkinson's disease

Liu YD, Li HF, Zhai YX, Shen YX, Yang J, He LM, Shen T.

Front Neurol. 2025 Jul 3;16:1598974. doi: 10.3389/fneur.2025.1598974. eCollection 2025.

Comparative Analysis of Progression Milestones Across Parkinson's Disease Clinical, Pathological, and Data-driven Subtypes: A 10-year follow-up

Negida A, Mukhopadhyay N, Berman BD, Barrett MJ.

Res Sq [Preprint]. 2025 Jun 23:rs.3.rs-6574563. doi: 10.21203/rs.3.rs-6574563/v1.

High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed dementia cohort

Gong K, Timsina J, Ali M, Chen Y, Liu M, Wang C, Pottier C, Feld GK, Heo G, Benzinger TLS, Raji CA, Ances B, Gordon BA, Wisch JK, Schindler SE, Morris JC, Holtzman DM, Ibanez L, Cruchaga C.

Res Sq [Preprint]. 2025 Jun 29:rs.3.rs-6440485. doi: 10.21203/rs.3.rs-6440485/v1.

Remote AI Screening for Parkinson's Disease: A Multimodal, Cross-Setting Validation Study

Islam MS, Adnan T, Abdelkader A, Liu Z, Ma E, Park S, Azad A, Liu P, Pawlik M, Hartman E, Shelton E, Larson KB, Rahman MS, Schwartz C, Jaffe K, Adams JL, Schneider RB, Freyberg J, Dorsey ER, Hoque E.

Res Sq [Preprint]. 2025 Jun 26:rs.3.rs-6844936. doi: 10.21203/rs.3.rs-6844936/v1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias